Thank you, Dominica, and good morning, good afternoon, good evening, to all of you. Thanks again for your attention and interest in Qiagen N.V. A year ago, and I hope and I think that most of you ...

As announced April 27, net sales for Q1 2026 rose 2% on a reported basis to $492 million, while sales at constant exchange rates (CER) were down 1%, compared with the outlook for at least 1% CER ...

Fintel reports that on April 29, 2026, Baird upgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Neutral to Outperform.

May 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations of the federal securities laws.

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 55 cents per share. The diagnostic products maker posted revenue of $492.3 million in the period, which ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new fully automated Sample to Insight workflow and a ...

Qiagen NV (NYSE:QGEN) is one of the 10 Stocks Reeling From Huge Losses. Shares of Qiagen nosedived to a seven-year low on ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Qiagen ...

April 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations of the federal securities ...

Sample technologies, QIAcuity and QDI deliver solid growth; QuantiFERON sales affected by significantly lower immigration ...

Qiagen N.V. (NYSE:QGEN) is one of the 10 potential takeover targets with strong price momentum. The latest relevant development came on April 14, 2026, when QIAGEN said it was expanding into ...